Worksheet ASU Table
1.1.
1 1.1.1 c
1.1.1. d-f
2 1.1.4.1 a / 1.1.4.2 a
3 1.2 c
4 1.3.1 a-b
5 1.3.2 a-b
Additional tables, to help you summarizing the data:
6
7
8
Title
Progress towards measles and rubella elimination 2018
Number of measles and rubella cases in 2018
Number of measles/rubella/CRS cases, by case classification and origin of
infection
Measles / Rubella outbreaks and sporadic cases in 2018 by availability of the
genotype information
Number of suspected cases tested in 2018 by type of the laboratory
Measles surveillance performance indicators (standard and alternative)
Rubella surveillance performance indicators (standard and alternative)
you summarizing the data:
Measles all cases, by regional level, classification category and month
Rubella all cases, by regional level, classification category and month
Measles cases by genotypes and sequence variants 2017-2019
Page in original ASU 2018
(empty form)
Page 8
Page 9
Pages 9-10
Page 12
Page 15
Page 18
Page 19
Page 20
Note:
Use for calculation and populate tables in ASU
Use for calculation and populate tables in ASU
Use for calculation and populate tables in ASU
Use for calculation and populate tables in ASU. Please see also
Annex 1.2 for guidelines
Use for calculation and populate tables in ASU. Please see also
Annex 1.2 for guidelines
PLEASE FILL IN ALL THE GREEN HIGHLIGHTED CELLS!
1.1 Progress towards measles and rubella elimination, 2016-2018
Tab 1.1 - only 2018 Fill in here:
Number of population (as used for ASU)
1.1.1 Epidemiology of measles, rubella and CRS in 2018
Tab 1.1.1 c Number of measles and rubella cases in 2018
Total cases classified* as
Total suspected cases measles and rubella
(calculated automatically) (calculated automatically from Tab
1.1.1 d-e)
Measles 0 0
Rubella 0 0
* Total of laboratory-confirmed, epidemiologically linked and clinically compatible cases, regardless of origin (include imported).
Tab 1.1.1 d Number of measles cases, by case classification and origin of infection
Measles cases classified as Laboratory-confirmed Epidemiologically linked
Imported
Import-related
Endemic
Unknown
Total (excluding imported cases)
0 0
(calculated automatically)
Tab 1.1.1 e Number of rubella cases, by case classification and origin of infection
Rubella cases classified as Laboratory-confirmed Epidemiologically linked
Imported
Import-related
Endemic
Unknown
Total (excluding imported cases)
(calculated automatically)
0 0
Tab 1.1.1 f Number of CRS cases, by case classification and origin of infection
CRS cases classified as Laboratory-confirmed Epidemiologically linked
Imported
Import-related
Endemic
Unknown
Total (excluding imported cases)
0 0
(calculated automatically)
(calculated automatically after completing
Tab 1.1 - only 2018 tables 1.1.1 d-f)
Incidence / No of cases 2018
Measles incidence per 1 million population #DIV/0!
Rubella incidence per 1 million population #DIV/0!
Number of CRS cases 0
Remarks
Discarded
If number of your suspected cases differs from the automatically calculated, please note here:
mported).
Total
Clinically compatible
(calculated automatically)
0
0
0
0
0 0
Total
Clinically compatible
(calculated automatically)
0
0
0
0
0 0
Total
Clinically compatible
(calculated automatically)
0
0
0
0
0 0
1.1.4 Outbreaks in 2018
Tab 1.1.4.1 a Measles outbreaks and sporadic cases in 2018 by availability of the genotype information
Genotyped
Number of outbreaks/chains of
transmission
Number of cases in the
outbreaks/chains of transmission
Number of sporadic cases that are
not part of chains of transmission
Total number of cases
(calculated automatically)
Tab 1.1.4.2 a Rubella outbreaks and sporadic cases in 2018 by availability of the genotype information
Genotyped
Number of outbreaks/chains of
transmission
Number of cases in the
outbreaks/chains of transmission
Number of sporadic cases that are
not part of chains of transmission
Total number of cases
(calculated automatically)
18 by availability of the genotype information
Not genotyped Total
0
0
0
0
18 by availability of the genotype information
Not genotyped Total
0
0
0
0
1.2 Laboratory performance
Tab 1.2. c Number of suspected cases tested in 2018 by type of the laboratory
Laboratory performing the Number of suspected cases tested Number of suspected cases tested
test for measles for rubella
WHO-accredited lab(s)
Proficient labs overseen by
WHO- accredited lab
Nationally accredited labs
Other labs
Total
0 0
(calculated automatically)
ratory
Number of suspected cases tested
for CRS
0
1.3.1 Measles surveillance performance indicators
ad 1.3.1 a Standard indicators
Measles Fill in here:
Number of reports submitted by the deadline
Number of submitted reports
Number of expected reports
Number of suspected measles cases with adequate specimens collected and tested in
a proficient laboratory 0
(automatically filled in)
Number of suspected cases
(automatically filled in (FUNCTION FORMULA ='Tab 1.1 & 1.1.1 c-f'!C12) BUT you can decrease the
number removing confirmed epidemiologicaly linked cases or cases discarded as non-measles by 0
epidemiological linkage to a laboratory-confirmed case of another communicable disease or
epidemiological linkage to a measles IgM-negative case)
Number of suspected measles cases investigated and discarded as non-measles cases
0
(automatically filled in)
Population
0
(automatically filled in)
Number of subnational administrative territories reporting the rate of discarded cases
at least 2 per 100 000 population per year
Number of subnational administrative territories
Number of chains of transmission of measles for which adequate samples have been
0
submitted for viral detection / genotyping (automatically filled in)
Number of chains of transmission identified
0
(automatically filled in)
Number of measles cases for which the origin of infection (e.g. imported, import-
related or endemic) has been identified 0
(automatically filled in)
The total number of measles cases
0
(automatically filled in)
Number of measles cases with an adequate investigation
Number of suspected measles cases
0
(automatically filled in)
ad 1.3.1 b Alternative indicators
Measles Fill in here:
Number of reports submitted within 48 hours
Number of suspected cases
0
(automatically filled in)
Number of measles-like cases tested negative for measles IgM
Population
0
(automatically filled in)
Tab 1.3.1 a Standard indicators (automatically calculated)
Notes: Measles
Regular monthly or weekly reports, including “zero” reports to be
Timeliness of reporting (to
submitted by each surveillance reporting unit to national level. This does
not refer to lab reporting of cases. The deadline to submit data on the national level) (in %)
previous months or week to be defined by Member State.
Completeness of reporting (to
national level) (in %)
Rate of laboratory investigations
(in %)
A single clinical sample obtained at the first contact with the health-care
system at any time within 28 days after rash onset is considered
adequate for surveillance purposes.Laboratory that is WHO accredited Rate of discarded cases
and/or has an established quality assurance programme with oversight
by a WHO accredited laboratory.
Exclude from the number any suspected cases not tested by a
laboratory and
(a) confirmed by epidemiological linkage, or
Representativeness of reporting
(b) discarded as non-measles by epidemiological linkage to a laboratory- discarded cases
confirmed case of another communicable disease or epidemiological (in %)
linkage to a measles IgM-negative case
Viral detection (in %)
Origin of infection identified
(in %)
Timeliness of investigation (in %)
Measles viruses can be detected in nasal secretions, urine, serum and
whole blood, and dry blood spots up to seven days after onset of the
rash and in oral fluid for even longer .
An adequate investigation includes the collection of at least the
following essential data elements from each suspected measles case:
case identifier, age (or date of birth), date of rash onset, date of
specimen collection and vaccination status. Countries may wish to
collect other data that may be important for epidemiologic
investigation.
Tab 1.3.1 b Alternative indicators (automatically calculated)
Measles
Timeliness of notification (in %;
alternative to Timeliness and
Completeness indicator)
Rate of cases tested negative for
measles IgM (N)
tandard indicators (automatically calculated)
Value, rate or
Numerator Denominator Description
percentage
Percentage of measles routine surveillance reports submitted to the
not applicable 0 0
national level by the deadline
Percentage of measles routine surveillance reports submitted to the
not applicable 0 0
national level
Percentage of cases suspected for measles with adequate
not applicable 0 0 specimensc collected and tested in a WHO accredited or proficient
laboratory
The rate of suspected measles cases investigated and discarded as
not applicable 0 0 non-measles cases using laboratory testing in a proficient laboratory
and/or epidemiological linkage to another confirmed disease
Percentage of subnational administrative territories (e.g. at the
not applicable 0 0 province level or its administrative equivalent) reporting the rate of
discarded cases at least 2 per 100 000 population per year
Percentage of laboratory-confirmed chains of transmission of
not applicable 0 0 measles with samples adequate for viral detection collected and
tested in an accredited laboratory
Percentage of measles cases for which the origin of infection
not applicable 0 0
(e.g. imported, import-related or endemic) has been identified
Percentage of suspected measles cases with an adequate
not applicable 0 0
investigation initiated within 48 hours of notification
lternative indicators (automatically calculated)
Rate or
Numerator Denominator Description
percentage
Alternative to Timeliness and Completeness of reporting
not applicable 0 0 Percentage of measles case-based reports to surveillance system
submitted within 48 hours of the rash onset
Alternative to Rate of discarded cases
not applicable 0 0 The rate of cases of measles-like illnesses (MLI) whose specimens
tested IgM negative in a proficient laboratory
1.3.2 Rubella surveillance performance indicators
ad 1.3.2 a Standard indicators
Rubella
Number of reports submitted by the deadline
Number of submitted reports
Number of expected reports
Number of suspected rubella cases with adequate specimens collected and tested in a proficient
laboratory
(automatically filled in)
Number of suspected cases
(automatically filled in (FUNCTION FORMULA IS ='Tab 1.1 & 1.1.1 c-f'!C13) BUT you can decrease the number by
removing confirmed epidemiologically linked cases or discarded as non-rubella by epidemiological linkage to a
laboratory-confirmed case of another communicable disease or epidemiological linkage to a rubella IgM-negative case)
Number of suspected rubella cases investigated and discarded as non-rubella cases (automatically
filled in)
Population
(automatically filled in)
Number of subnational administrative territories reporting the rate of discarded cases at least 2
per 100 000 population per year
Number of subnational administrative territories
Number of chains of transmission of rubella for which adequate samples have been submitted for
viral detection / genotyping (automatically filled in)
Number of chains of transmission identified
(automatically filled in)
Number of rubella cases for which the origin of infection (e.g. imported, import-related or
endemic) has been identified
(automatically filled in)
The total number of rubella cases
(automatically filled in)
Number of rubella cases with an adequate investigation
Number of suspected rubella cases
(automatically filled in)
ad 1.3.2 b Alternative indicators
Rubella
Number of reports submitted within 48 hours
Number of suspected cases
(automatically filled in)
Number of rubella cases tested negative for rubella IgM
Population
(automatically filled in)
Fill in here: Notes:
Regular monthly or weekly reports, including “zero” reports to be submitted by each
surveillance reporting unit to national level. This does not refer to lab reporting of cases.
The deadline to submit data on the previous months or week to be defined by Member
State
A single clinical sample obtained at the first contact with the health-care system at any
time within 28 days after rash onset is considered adequate for surveillance purposes.
0 Laboratory that is WHO accredited and/or has an established quality assurance
programme with oversight by a WHO accredited laboratory.
Exclude from the number any suspected cases not tested by a laboratory and
(a) confirmed by epidemiological linkage, or
0 (b) discarded as non-rubella by epidemiological linkage to a laboratory-confirmed case of
another communicable disease or epidemiological linkage to a rubella IgM-negative case
0
0
Rubella viruses can be detected in nasal secretions, urine, serum and whole blood, and dry
0 blood spots up to seven days after onset of the rash and in oral fluid for even longer .
0
0
0
An adequate investigation includes the collection of at least the following essential data
elements from each suspected rubella case: case identifier, age (or date of birth), date of
rash onset, date of specimen collection and vaccination status. Countries may wish to
collect other data that may be important for epidemiologic investigation
0
Fill in here:
0
0
Tab 1.3.2 a Standard indicators (automatically calculated)
Rubella Value, rate or percentage Numerator Denominator
Timeliness of reporting (to national level) (in %) not applicable 0 0
Completeness of reporting (to national level)
not applicable 0 0
(in %)
Rate of laboratory investigations (in %) not applicable 0 0
Rate of discarded cases not applicable 0 0
Representativeness of reporting discarded
cases not applicable 0 0
(in %)
Viral detection (in %) not applicable 0 0
Origin of infection identified
not applicable 0 0
(in %)
Timeliness of investigation (in %) not applicable 0 0
Tab 1.3.2 b Alternative indicators (automatically calculated)
Rubella Value, rate or percentage Numerator Denominator
Timeliness of notification (in %; alternative to
not applicable 0 0
Timeliness and Completeness indicator)
Rate of cases tested negative for rubella IgM
not applicable 0 0
(N)
Description
Percentage of rubella routine surveillance reports submitted to the national level by the
deadline
Percentage of rubella routine surveillance reports submitted to the national level
Percentage of cases suspected for rubella with adequate specimens collected and tested
in a WHO accredited or proficient laboratory
The rate of suspected rubella cases investigated and discarded as non-rubella cases
using laboratory testing in a proficient laboratory and/or epidemiological linkage to
another confirmed disease
Percentage of subnational administrative territories (e.g. at the province level or its
administrative equivalent) reporting the rate of discarded cases at least 2 per 100 000
population per year
Percentage of laboratory-confirmed chains of transmission of rubella with samples
adequate for viral detection collected and tested in an accredited laboratory
Percentage of rubella cases for which the origin of infection (e.g. imported, import-
related or endemic) has been identified
Percentage of suspected rubella cases with an adequate investigation initiated within 48
hours of notification
Description
Alternative to Timeliness and Completeness of reporting
Percentage of rubella case-based reports to surveillance system submitted within 48
hours of the rash onset
Alternative to Rate of discarded cases
The rate of cases of rubella-like illnesses (RLI) whose specimens tested IgM negative in a
proficient laboratory
Measles 2018 - number of cases
Jan Feb Mar
Suspected (calculated automatically) 0 0 0
Discarded
Classified as measles (calculated automatically) 0 0 0
National level Clinical
(population)
Epid-link
Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as (calculated automatically) 0 0 0
administrative level - Clinical
no. 1 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as measles (calculated automatically) 0 0 0
administrative level - Clinical
no. 2 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as measles (calculated automatically) 0 0 0
administrative level - Clinical
no. 3 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as measles (calculated automatically) 0 0 0
administrative level - Clinical
no. 4 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
add as many as subnational administrative units of that level you have in country
national level data should be sum of subnational level data
Apr May Jun Jul Aug Sep Oct Nov Dec
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
Total
Rules
(calculated automatically)
0
0 Suspected = Discarded + Classified as
0
Classified as measles = Clinical + Epid-link +
0
0
0 Classified as measles = Outbreak cases + Sporadic cases
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Lab confirmed
Rubella 2018 - number of cases
Jan Feb Mar
Suspected (calculated automatically) 0 0 0
Discarded
Classified as rubella (calculated automatically) 0 0 0
National level Clinical
(population)
Epid-link
Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as rubella (calculated automatically) 0 0 0
administrative level - Clinical
no. 1 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as rubella (calculated automatically) 0 0 0
administrative level - Clinical
no. 2 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as rubella (calculated automatically) 0 0 0
administrative level - Clinical
no. 3 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
Suspected (calculated automatically) 0 0 0
Discarded
1st subnational Classified as rubella (calculated automatically) 0 0 0
administrative level - Clinical
no. 4 Epid-link
(population) Lab confirmed
Outbreak cases
Sporadic cases
add as many as subnational administrative units of that level you have in country
national level data should be sum of subnational level data
Apr May Jun Jul Aug Sep Oct Nov Dec
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
Total
Rules
(calculated automatically)
0
0 Suspected = Discarded + Classified as
0
Classified as rubella = Clinical + Epid-link +
0
0
0 Classified as rubella = Outbreak cases + Sporadic cases
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Lab confirmed
Measles cases by genotypes and sequence variants 2017-2019
Genotype Sequence variant
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
National level Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
1st administrative level - Outbreak cases
no. 1 Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
1st administrative level -
no. 2
Sporadic cases
Outbreak cases
Sporadic cases
1st administrative level - Outbreak cases
no. 2 Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
1st administrative level - Outbreak cases
no. 3 Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
1st administrative level - Outbreak cases
no. 4 Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
no. 4
Sporadic cases
Outbreak cases
Sporadic cases
Outbreak cases
Sporadic cases
add as many as subnational administrative units of that level you have in country
add/remove genotype and variant data as per their detection at subnational level
national level data should be sum of subnational level data
-2019
okt.17 nov.17 dets.17 jaan.18 veebr.18 märts.18 apr.18 mai.18 juuni.18
juuli.18 aug.18 sept.18 okt.18 nov.18 dets.18 jaan.19 veebr.19 märts.19
Saatja: Elen Ohov <
[email protected]>
Saadetud: 08.03.2019 13:31
Adressaat: SM Info <
[email protected]>
Teema: FW: Annual status update on measles and rubella elimination-2018 CRM:0081049
Manused: Annual status update on measles and rubella elimination.pdf; ENG ASU 2018.docx;
ENG Excel tool ASU 2018.xlsx
From: Florencia Biviano <
[email protected]>
Sent: Tuesday, March 5, 2019 3:45 PM
To: Elen Ohov <
[email protected]>
Cc: Andre Pung <
[email protected]>; EURO RVC <
[email protected]>; Marge Reinap
<
[email protected]>; Märt Volmer <
[email protected]>; Triin Uusberg
<
[email protected]>
Subject: Annual status update on measles and rubella elimination-2018 CRM:0081049
Please see the attached correspondence sent from the World Health Organization, Regional
Office for Europe. One or more attachments may be included.
Veuillez vous référer à la correspondance ci-jointe du Bureau régional de l'Europe de
l'Organisation mondiale de la santé. Une ou plusieurs annexes peuvent être jointes.
Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen),
Weltgesundheitsorganisation, Regionalbüro für Europa
См. прикрепленные письма от Европейского регионального бюро Всемирной организации
здравоохранения (один или несколько прикрепленных файлов).
WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION Date: 05 March 2019
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONAL OFFICE FOR EUROPE Ms Elen Ohov
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co-
Head office:
operation Department
UN City, Marmorvej 51, Ministry of Social Affairs
DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected] 10122 Tallinn
Website: http://www.euro.who.int Estonia
Our reference: Your reference:
Notre référence: Votre référence:
Unser Zeichen: Ihr Zeichen:
См. наш номер: На Ваш номер:
Dear Ms Ohov,
Annual status update (ASU) on measles and rubella elimination – 2018
The Vaccine-preventable Diseases and Immunization programme (VPI) of the WHO Regional Office
for Europe is pleased to inform you that the eighth meeting of the European Regional Verification
Commission for Measles and Rubella Elimination (RVC) will be held in June 2019, to review status
and achievements towards measles and rubella elimination in countries and in the Region. The RVC
will base its decision on the status of measles and rubella elimination in each Member State and the
Region on three consecutive reports submitted by the respective national verification committees
(NVCs).
All Member States are requested to submit their ASU on measles and rubella elimination activities for
the year 2018 with all relevant information no later than 15 April 2019. Adhering to this deadline is
essential to ensure sufficient time for the analysis of data before the RVC meets. An ASU template for
2018 and all additional documents, prepared and approved by the respective NVC, should be
submitted via SharePoint or by e-mail (
[email protected]) to the WHO Regional Office for Europe
(RVC Secretariat). We kindly ask you to use the credentials and instructions for using SharePoint as
previously provided.
Attached you will find a template for the 2018 ASU. To ensure consistency, please follow the
proposed format as explained in the instructions. To facilitate your work on preparation of the ASU
2018, please use an Excel file and its pre-prepared tables with formulas that will help you in
calculating data. A few extra worksheets are developed to facilitate analysis of data at subnational
level and to allow presenting detailed molecular epidemiology information if available, for your
convenience. We recommend to submit this file together with ASU 2018.
In addition, we encourage you to submit any additional information that will assist the RVC in
determining the status of measles and rubella elimination in your country. Additional information that
does not fit in the template may be uploaded as a separate document. VPI stands ready to support you
in ensuring timely completion of the ASU.
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int
Denmark
We would like to take this opportunity to re-emphasize the importance of ensuring that data submitted
in this annual update are accurate and consistent with other national reports submitted to the Regional
Office.
We would also like to stress that all reports and additional information received from the NVCs
during the verification process will be carefully reviewed and analysed. RVC conclusions based on
this information will be publicly presented in various forms, as part of planned communication
activities to recognize Member States’ efforts and progress towards the Region’s immunization goals.
Should you have any questions regarding the provided template and uploading of documents, please
contact Dr Dragan Jankovic (
[email protected]), Dr Zhanara Bekenova (
[email protected]) and
Ms Florencia Biviano (
[email protected]).
We would like to stress that your efforts in documenting the absence of endemic transmission in your
country are highly appreciated and critical to achieving measles and rubella elimination in the Region.
The RVC and Secretariat are committed to providing you with any support that you may require.
Sincerely yours,
Dr Siddhartha Datta
Programme Manager
Vaccine-preventable Diseases
and Immunization
Copy for information to:
Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs,
Suur-Ameerika 1, 10129 Tallinn, Estonia
H.E. Mr Andre Pung, Ambassador, Permanent Mission of the Republic of Estonia to the United Nations Office
and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève,
Switzerland
H.E. Mr Märt Volmer, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia,
Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark
Ms Marge Reinap, Head of WHO Office, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn,
Estonia
EURO RVC, World Health Organization Regional Office for Europe, Denmark
–2–